azomycin has been researched along with Esophagitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeff, M; Badar, T; Benito, JM; Borthakur, G; Cortes, JE; Faderl, S; Handisides, DR; Harutyunyan, K; Jabbour, E; Kantarjian, HM; Konoplev, S; Konopleva, M; Kroll, S; Pearce, T; Richie, MA; Thomas, DA | 1 |
| Hansen, HH; Kjaer, M; Panduro, J; Wolff-Jensen, J | 1 |
| Marin-Neto, JA; Simões, MV; Soares, FA | 1 |
2 trial(s) available for azomycin and Esophagitis
| Article | Year |
|---|---|
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.
Topics: Adult; Aged; Bone Marrow; Esophagitis; Female; Humans; Hyperbilirubinemia; Hypoxia; Leukemia; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Nitroimidazoles; Phosphoramide Mustards; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prodrugs; Salvage Therapy; Stomatitis; Young Adult | 2016 |
Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
Topics: Aged; Carcinoma, Squamous Cell; Double-Blind Method; Esophagitis; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Placebos; Pneumonia; Radiation Injuries; Radiotherapy Dosage; Random Allocation; Vomiting | 1983 |
1 other study(ies) available for azomycin and Esophagitis
| Article | Year |
|---|---|
Severe myocarditis and esophagitis during reversible long standing Chagas' disease recrudescence in immunocompromised host.
Topics: Adult; Chagas Cardiomyopathy; Esophagitis; Female; Humans; Immunocompromised Host; Nitroimidazoles; Trypanocidal Agents; Ultrasonography | 1995 |